ACIU Dividend: AC Immune SA Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

ACIU Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	4	27	14	3	0	15
Revenue Growth (YoY)	-90%	93%	367%	--	-100%	-86%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	11	11	10	9	10	11
Research & Development	61	62	54	60	62	59
Operating Expenses	77	79	68	74	79	76
Other Non Operating Income (Expenses)	--	--	--	--	0	0
Pretax Income	-71	-50	-54	-70	-73	-61
Income Tax Expense	0	0	0	0	0	0
Net Income	-71	-50	-54	-70	-73	-61
Net Income Growth	82%	-7%	-23%	-4%	20%	-236%
Shares Outstanding (Diluted)	100.89	99.69	84.69	83.6	75	71.9
Shares Change (YoY)	0%	18%	1%	11%	4%	1%
EPS (Diluted)	-0.71	-0.51	-0.64	-0.85	-0.97	-0.86
EPS Growth	75%	-20%	-25%	-12%	13%	-234%
Free Cash Flow	-47	65	-61	-74	-68	-61
Free Cash Flow Per Share	-0.46	0.65	-0.72	-0.88	-0.9	-0.84
Gross Margin	--	--	--	--	--	--
Operating Margin	-1,825%	-192.59%	-378.57%	-2,333.33%	0%	-406.66%
Profit Margin	-1,775%	-185.18%	-385.71%	-2,333.33%	0%	-406.66%
Free Cash Flow Margin	-1,175%	240.74%	-435.71%	-2,466.66%	0%	-406.66%
EBITDA	-71	-50	-51	-68	-77	-60
EBITDA Margin	-1,775%	-185.18%	-364.28%	-2,266.66%	0%	-400%
D&A For EBITDA	2	2	2	2	2	1
EBIT	-73	-52	-53	-70	-79	-61
EBIT Margin	-1,825%	-192.59%	-378.57%	-2,333.33%	0%	-406.66%
Effective Tax Rate	0%	0%	0%	0%	0%	0%